Beta Bionics, Inc. · NASDAQ:BBNX
Feider Stephen sold 10,000 Beta Bionics, Inc. shares (Form 4)
Traded Jun 26 to Jun 29, 2026 · Filed Jun 30, 2026
From Jun 26 to Jun 29, 2026, Feider Stephen (Chief Financial Officer) sold 10,000 Beta Bionics, Inc. shares at an average US$17.04 for US$170K under a trading plan, leaving 165,931 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$17.04 average (US$17.03 to US$17.05)
- Value
- US$170K
- Holding after
- 165,931 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Option exercise | 4,982 | US$5.10 | 171,035 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 5,104 | US$17.05 | 165,931 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 4,896 | US$5.10 | 170,827 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 4,896 | US$17.03 | 165,931 | Direct |
Source
Related
- Beta Bionics, Inc.
- Feider Stephen
- Beta Bionics, Inc. shareholders
- Form 4 · Feider Stephen · Sep 3, 2026
- Form 4/A · Feider Stephen · Jul 2, 2026
- Form 4 · Feider Stephen · Jun 3, 2026
- Form 4 · Hopman Mark · Oct 16, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026